We specialise in the development and commercialisation of high-end minimally invasive products. These products target diseases associated with general, bariatric, thoracic and colorectal procedures. We are committed to providing comprehensive and integrated solutions to the global market. Our commitment is to the development of “best-in-class” devices rooted in strong clinical and health-economic evidence that supports the entire patient care continuum. We are driven by our core mission of meeting and exceeding the four pillars of our global strategy, “EFFECTIVE, LEARNING, INNOVATIVE, BENEFICIAL”. We remain solutions-focused and provide products that improve clinical outcomes and reduce the cost of healthcare.